{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/68b89d25d6e2cdaa2670b2da/68b8a02c093397eb054ac863?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Consensus in Action: Endocrinologists and Management of Patients with Thyroid Eye Disease (TED)","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/68b89d25d6e2cdaa2670b2da/1756930087191-33eb4800-ff2f-48cc-ac91-9df278a1bdf5.jpeg?height=200","description":"<p>In this episode, Dr Dhruv discusses TED patient identification and management based on the published American Thyroid Association (ATA)/European Thyroid Association (ETA) consensus statement, including the use of TEPEZZA® (teprotumumab-trbw) for treatment regardless of disease activity or duration.&nbsp;</p>","author_name":"Kathryn Ryan"}